Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet Income
Growth Metrics
Income Statement
Others
Ratios

Medicale (MCLE) Cash from Financing Activities (2020 - 2025)

Medicale's Cash from Financing Activities history spans 6 years, with the latest figure at $6457.0 for Q3 2025.

  • For Q3 2025, Cash from Financing Activities fell 58.37% year-over-year to $6457.0; the TTM value through Sep 2025 reached $22849.0, down 72.66%, while the annual FY2025 figure was $22849.0, 72.66% down from the prior year.
  • Cash from Financing Activities reached $6457.0 in Q3 2025 per MCLE's latest filing, up from $2021.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $31082.0 in Q1 2024 to a low of $188.0 in Q2 2021.
  • Average Cash from Financing Activities over 5 years is $10424.3, with a median of $7348.5 recorded in 2023.
  • Peak YoY movement for Cash from Financing Activities: soared 1277.66% in 2022, then crashed 85.94% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at $650.0 in 2021, then soared by 733.54% to $5418.0 in 2022, then skyrocketed by 411.37% to $27706.0 in 2023, then crashed by 63.91% to $10000.0 in 2024, then plummeted by 35.43% to $6457.0 in 2025.
  • Per Business Quant, the three most recent readings for MCLE's Cash from Financing Activities are $6457.0 (Q3 2025), $2021.0 (Q2 2025), and $4371.0 (Q1 2025).